Instalab

Hemp (Can s 3) IgE Test Blood

See whether your immune system is reacting to hemp, even when broader allergy panels miss the cause.

Should you take a Hemp (Can s 3) IgE test?

This test is most useful if any of these apply to you.

Reacting Around Cannabis or Hemp
You have had itching, hives, breathing trouble, or stomach symptoms after handling cannabis, smoking, or eating hemp products.
Already Allergic to Plant Foods
You react to peach, peanut, hazelnut, or walnut and want to know whether your sensitization extends to hemp and related plants.
Working Around Cannabis Daily
You cultivate, process, or handle cannabis or hemp at work and want to know whether occupational exposure is triggering your immune system.
Investigating Unexplained Anaphylaxis
You have had a severe allergic reaction without a clear cause and want to rule in or out a lipid transfer protein allergy pattern.

About Hemp (Can s 3) IgE

If you have had an unexplained reaction after handling, eating, or being around cannabis or hemp, this test can help pin down whether your immune system is the culprit. It looks for a very specific antibody, IgE (immunoglobulin E, the antibody class your body makes against allergens), that targets a single hemp protein called Can s 3.

Can s 3 is the most clinically important hemp allergen identified so far. Measuring antibodies against just this one component, rather than a crude hemp extract, gives you a more precise read on whether you are truly sensitized to hemp itself, and whether you may be at risk of reactions to other plant foods that share similar proteins.

What This Test Actually Measures

Can s 3 belongs to a family of plant proteins called non-specific lipid transfer proteins (nsLTPs), small, sturdy molecules that plants make to protect themselves from stress. These proteins survive cooking and digestion, which is why allergies to them can produce serious reactions rather than just mild mouth itching. When your immune system mistakenly tags Can s 3 as a threat, it produces IgE antibodies specifically against it. This test measures the concentration of those antibodies in your blood.

Because Can s 3 is structurally similar to lipid transfer proteins in other plants (peach, peanut, hazelnut, walnut, mugwort and others), a positive Can s 3 result often shows up alongside reactions to seemingly unrelated foods. This is the value of component testing: it can explain a pattern of reactions that a generic allergy panel cannot.

How Sensitive and Specific Is It?

This is a Tier 2 to Tier 3 marker. It has published cutoffs and validation work, but the decision threshold matters a great deal, and a single number should never be interpreted in isolation from your symptoms.

In a study of cannabis-allergic patients compared with controls, the blood test for Can s 3 IgE performed differently at different cutoffs and using different lab methods. Numbers like sensitivity (the percentage of truly allergic people the test catches) and specificity (the percentage of non-allergic people it correctly clears) help you understand the trade-offs.

Lab methodWho it catchesWho it correctly clears
Fluorescence enzyme immunoassay (low cutoff)A majority of cannabis-allergic peopleA majority of non-allergic people
Cytometric bead assayRoughly half of cannabis-allergic peopleMost non-allergic people
Basophil activation testAbout half of respondersMost non-allergic people

Source: Ebo et al., 2025. What this means for you: a positive result at very low levels is more likely to reflect background sensitization without clinical reactions. Higher levels, especially combined with a real-world history of symptoms after cannabis or hemp exposure, are more meaningful. Conventional cutoffs tend to agree better with functional tests that measure actual immune cell activation.

Why It Matters: Reactions and Severity

Allergies to lipid transfer proteins, the family Can s 3 belongs to, are not just nuisance reactions. They can cause everything from itchy mouth to anaphylaxis (a severe, whole-body allergic reaction). In a large study of people with lipid transfer protein sensitization, having IgE against multiple proteins in this family was linked to a higher rate of food-induced systemic reactions, meaning reactions that affect more than just the area of contact.

For cannabis specifically, reactions can come from inhaling pollen or smoke, handling the plant, or eating hemp seeds, hemp oil, or hemp protein. As hemp-based foods and cannabis use have become more common, the population at risk of these reactions has grown. Knowing whether you carry Can s 3 IgE can help explain past reactions and help you anticipate cross-reactions to related plants.

Cross-Reactivity: The Pattern That Matters Most

Because lipid transfer proteins are similar across many plants, sensitization to Can s 3 often travels with sensitization to other nsLTPs. The most studied of these is Pru p 3, the lipid transfer protein in peach, which is considered the central marker for this whole family of allergies. People who react to Can s 3 may also react to peach, peanut, hazelnut, walnut, mugwort pollen, or other plant foods that contain similar proteins.

In a cohort study, the ratio of Pru p 3 IgE to total IgE was among the best markers for distinguishing true clinical lipid transfer protein allergy from harmless sensitization. This is why Can s 3 testing is rarely done alone. Your result will be most useful when interpreted alongside other lipid transfer protein components to build a full picture of which plants are most likely to trigger you.

When Results Can Be Misleading

A few things to keep in mind when interpreting your number:

  • Low positives can mislead: weakly positive results are often not confirmed by functional tests like the basophil activation test, which measures actual immune cell reactivity. A weakly positive number does not necessarily mean you will have symptoms.
  • Symptoms still rule: a positive blood test without a history of real-world reactions is sensitization, not allergy. Sensitization means your body has made the antibody but may never produce symptoms.
  • The lab method matters: different assays use different cutoffs and produce different sensitivities. If you retest at a different lab, compare results cautiously.
  • Cross-reactivity can confuse: a positive Can s 3 result may reflect primary sensitization to a related plant lipid transfer protein (often peach) rather than direct hemp exposure.

Tracking Your Trend

A single Can s 3 IgE measurement gives you a snapshot, but the more useful information comes from watching the trend. IgE levels can shift over months and years based on continued exposure, avoidance, or treatment. If you are starting a new exposure pattern (using hemp-based products, beginning cannabis use, changing your diet), a baseline test now and a follow-up in 6 to 12 months can show whether your sensitization is rising, falling, or stable.

Tracking is also useful if you are working with an allergist on an avoidance strategy or considering allergen immunotherapy in the future. The number itself is one input; the direction of change over time tells you whether your immune response is escalating or quieting down.

What to Do With an Unexpected Result

If your Can s 3 IgE comes back positive, the next step is not to panic but to map the picture. Consider ordering or asking about a broader lipid transfer protein panel, including Pru p 3 (peach), Ara h 9 (peanut), Cor a 8 (hazelnut), Jug r 3 (walnut), and Art v 3 (mugwort). This builds a profile of which plants you are most likely to react to.

A positive result combined with a history of unexplained reactions (especially anaphylaxis, hives, swelling, or severe digestive symptoms after eating plant foods or being around cannabis) warrants a visit to an allergist or immunologist. They can interpret your full component profile, consider functional testing like a basophil activation test, and, if appropriate, prescribe an epinephrine auto-injector. If your result is positive but you have no symptoms, you may not need to change anything, but you should know which exposures to watch.

Frequently Asked Questions

References

7 studies
  1. Ebo D, Mertens CM, Van Houdt M, Hagendorens M, Rihs H, Toscano a, Beyens M, Sabato V, Van Gasse AV, Elst JClinical and Experimental Allergy2025
  2. Scala E, Till SJ, Asero R, Abeni D, Guerra E, Pirrotta L, Paganelli R, Pomponi D, Giani M, Pita OD, Cecchi LAllergy2015
  3. Skypala I, Asero R, Barber D, Cecchi L, Diaz Perales a, Hoffmann-sommergruber K, Pastorello E, Swoboda I, Bartra J, Ebo D, Faber M, Fernandez-rivas M, Gomez F, Konstantinopoulos a, Luengo O, Van Ree R, Scala E, Till SClinical and Translational Allergy2021
  4. Olivieri B, Scadding G, Skypala IClinical and Translational Allergy2025
  5. Toscano a, Ebo D, Abbas KF, Brucker H, Decuyper I, Naimi D, Nanda a, Nayak a, Skypala I, Sussman G, Zeiger J, Silvers WAnnals of Allergy, Asthma & Immunology2022